(Source: Baylor Health Care System) Local researcher who participated in national hepatitis C drug study available to comment on results published today in New England Journal of Medicine 11/17/2015 - DALLAS Worldwide, 170 million people have chronic hepatitis C infection. As the population with the hepatitis C virus ages, the proportion of patients with symptomatic cirrhosis is expected to increase. Current oral medications do not work for all kinds (or genotypes) of the virus or in patients with advanced disease. Now, there is a combination of medications that works to cure patients infected with every genotype - even with advanced disease. Jacqueline G. O'Leary, MD, MPH, transplant...
↧